Charles Howe, Ph.D. (N ’03), received an award, Mayo Clinic Rochester

Charles Howe, Ph.D. (N ’03), chair, Division of Experimental Neurology at Mayo Clinic in Rochester, received a 2023 research award from the Minnesota Partnership for Biotechnology and Medical Genomics for the project Organoid Biomanufacturing for Transforming Healthcare. The Minnesota Partnership for Biotechnology and Medical Genomics is a collaborative venture among Mayo Clinic, the University of Minnesota and the state of Minnesota that seeks to position Minnesota as a world leader in biotechnology and medical genomics applications that will result in important new medical discoveries that improve healthcare for patients while supporting the development of new businesses and jobs in the state. Dr. Howe’s partner at the University of Minnesota is Brenda Ogle, Ph.D. In this study, researchers will create agile, reproducible and physiologically relevant models (organoids) of human hearts, brains and intestines that can be used as tools for understanding diseases, testing new treatments and even replacing damaged cells in patients. Dr. Howe is a professor of neurology and an associate professor of neuroscience in the Mayo Clinic College of Medicine and Science.